Saint Francis Accredited as Level 3 Epilepsy Center

The Saint Francis Healthcare System Neurosciences Institute Epilepsy Center received accreditation from the National Association of Epilepsy Centers (NAEC) as a Level 3 Epilepsy Center.  

Nearly 3.5 million people across the United States are affected by active epilepsy. Epilepsy is classified as a pathology of the brain that causes a tendency to have recurrent seizures, and can come from different areas of the brain with multiple methods of treatment. Level 3 Epilepsy Centers have the professional expertise and facilities to provide the highest level medical evaluation and treatment for patients with complex epilepsy.

“This is a substantial achievement for the Saint Francis Epilepsy Center,” shared Mark E. Farrenburg, MD, neurologist and epileptologist at Saint Francis. “This accreditation really sets Saint Francis apart from other hospital systems in the area and is a testament to the high level of care our program provides.”

Level 3 is the highest level for centers who do not perform epilepsy surgery directly. As the only center between St. Louis and Memphis, the Saint Francis Epilepsy Center brings the capabilities and services usually reserved only for larger cities, including an Epilepsy Monitoring Unit, ICU continuous EEG monitoring capabilities, routine and ambulatory EEG, 3T epilepsy protocol MRI, neuropsychology services and management of neuromodulary devices such as RNS, DBS and VNS. In cases of medication resistant epilepsy, the Saint Francis Epilepsy Center performs local epilepsy surgery evaluations and develops a joint surgical plan with outside surgery centers while remaining involved throughout the process.

“Receiving accreditation from the NAEC marks a significant milestone for the Saint Francis Epilepsy Center, distinguishing Saint Francis as a leader in epilepsy care,” stated Lisa Newcomer, RRT, MBA, FACHE, Vice President of Regional Operations for Saint Francis. “This achievement reflects our dedication to expanding access to top-tier services and is a testament to our ongoing efforts to deliver exceptional care to every patient we serve.”

“I hope this recognition helps us expand our reach and provide excellent care to every single epilepsy patient in the region,” said Farrenburg.